← Back to home

Document DOJ-OGR-00026019

AI Analysis

Summary: An email chain between the Chief Pharmacist and Supervisory Staff Attorney at MCC New York discusses an inmate's medication, confirming that the inmate has an active Vascepa prescription but no record of a back pain medication prescription. The attorneys had alleged the inmate was not receiving necessary medication.
Significance: This email chain reveals a potential issue with an inmate's access to medication, specifically Vascepa and back pain medication, and the communication between the prison's pharmacy and legal staff regarding the inmate's treatment.
Key Topics: inmate medication Vascepa prescription back pain treatment
Key People:
  • (b)(6); (b)(7)(C) - Chief Pharmacist at MCC New York
  • (b)(6); (b)(7)(C) - Supervisory Staff Attorney at CLC New York
Document Type
Email
Date
July 30, 2019
Pages
1
Folder
IMAGES010

Full Text

Page 2250 Good Morning, He has active refillable Rx-Vascepa which was dispensed on 7/17 for a 30 day supply..? We can place them on PL starting tomorrow. Vascepa is on order. No rx for back pain on file. Thank You, (b)(6); (b)(7)(C) PharmD, MS, BCACP CAPT, U.S. Public Health Service Chief Pharmacist MCC New York 150 Park Row, New York, NY 10007 (b)(6); (b)(7)(C)@bop.gov Phone: (646) 836-(b)(6); (b)(7)(C) Fax: (646) 836-7680 "This message is intended for official use and may contain SENSITIVE information. If this message contains SENSITIVE information, it should be properly delivered, labeled, stored, and disposed of according to policy." Commissioned Corps of the United States Public Health Service - "Protecting, promoting, and advancing the health and safety of the Nation" >> (b)(6); (b)(7)(C) 7/30/2019 7:48 AM >>> Good morning all, The above inmate's attorneys have recently alleged he is not receiving cholesterol or back pain medication. Please see him for these and other complaints. Thank you, (b)(6); (b)(7)(C) (b)(6); (b)(7)(C) Supervisory Staff Attorney CLC New York Metropolitan Correctional Center 150 Park Row New York, New York 10007 p: (646)836-(b)(6); (b)(7)(C) f: (646)836-7665 Page 12842 DOJ-OGR-00026019